EDRH
DFTX

Edmond de Rothschild Holding’s Definium Therapeutics DFTX Stock Holding History

Edmond de Rothschild Holding’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-666
Closed -$2.44K – 700
2023
Q4 		$2.44K Hold
666
– – ﹤0.01% 684
2023
Q3 		$2.08K Hold
666
– – ﹤0.01% 700
2023
Q2 		$2.38K Hold
666
– – ﹤0.01% 714
2023
Q1 		$2.11K Hold
666
– – ﹤0.01% 719
2022
Q4 		$1.47K Hold
666
– – ﹤0.01% 778
2022
Q3 		$2K Sell
666
-1
-0.1% -$10 ﹤0.01% 818
2022
Q2 		$6K Buy
+667
New +$8.44K ﹤0.01% 777
2022
Q1 		– Sell
-667
Closed -$14K – 835
2021
Q4 		$14K Buy
+667
New +$21.3K ﹤0.01% 783

Other funds holding DFTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Edmond de Rothschild Holding's DFTX Position: Q1 2024 in Review

Edmond de Rothschild Holding sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 666 shares — an estimated $2.44K sold.

Edmond de Rothschild Holding first reported a position in DFTX in Q4 2021 and held it in 8 quarters. The position peaked at $14K in Q4 2021. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Edmond de Rothschild Holding reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 666 Definium Therapeutics shares in Q1 2024, an estimated $2.44K.
  • Edmond de Rothschild Holding first reported a position in Definium Therapeutics in Q4 2021 and held it in 8 quarters.
  • Edmond de Rothschild Holding's Definium Therapeutics position peaked at $14K in Q4 2021.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2024, filed 8 May 2024.